Correlation Between Mineralys Therapeutics, and Quantum Si

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Quantum Si at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Quantum Si into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Quantum Si incorporated, you can compare the effects of market volatilities on Mineralys Therapeutics, and Quantum Si and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Quantum Si. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Quantum Si.

Diversification Opportunities for Mineralys Therapeutics, and Quantum Si

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Mineralys and Quantum is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Quantum Si incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Si incorporated and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Quantum Si. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Si incorporated has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Quantum Si go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Quantum Si

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Quantum Si. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 6.74 times less risky than Quantum Si. The stock trades about -0.06 of its potential returns per unit of risk. The Quantum Si incorporated is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest  6.75  in Quantum Si incorporated on August 29, 2024 and sell it today you would earn a total of  30.25  from holding Quantum Si incorporated or generate 448.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Quantum Si incorporated

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Quantum Si incorporated 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Si incorporated are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quantum Si showed solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics, and Quantum Si Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Quantum Si

The main advantage of trading using opposite Mineralys Therapeutics, and Quantum Si positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Quantum Si can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Si will offset losses from the drop in Quantum Si's long position.
The idea behind Mineralys Therapeutics, Common and Quantum Si incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments